XRAY vs HSIC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

XRAY

44.3
AI Score
VS
HSIC Wins

HSIC

52.4
AI Score

Investment Advisor Scores

XRAY

44score
Recommendation
HOLD

HSIC

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY HSIC Winner
Forward P/E 6.3291 14.8148 XRAY
PEG Ratio 0.633 1.7438 XRAY
Revenue Growth -4.1% 6.7% HSIC
Earnings Growth 15.2% 17.1% HSIC
Tradestie Score 44.3/100 52.4/100 HSIC
Profit Margin -15.0% 3.0% HSIC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: -18.8% · 3M: -25.0% HSIC 1M: -4.1% · 3M: -1.7%

Current Technical Phase

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $8.74

HSIC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.7 · Price: $84.93

Fundamentals Snapshot

Metric XRAY HSIC
Market Cap — —
Forward P/E 5.8 14.2
Trailing P/E — 24.8
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.1% 0.1%
EPS -2.69 3.39
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, HSIC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.